Explore

Trendline Trendline
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study

Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study

Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study
Trendline Trendline
Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study, Aiming to Treat Calcified Arterial Disease

Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study, Aiming to Treat Calcified Arterial Disease

Stryker's AVS Enrolls First Patient in Coronary Intravascular Lithotripsy Study, Aiming to Treat Calcified Arterial Disease
Trendline Trendline
Boston Scientific Invests $1.5 Billion in MiRus LLC for Cardiovascular Innovations

Boston Scientific Invests $1.5 Billion in MiRus LLC for Cardiovascular Innovations

Boston Scientific Invests $1.5 Billion in MiRus LLC for Cardiovascular Innovations
Trendline Trendline
Tulyp Medical Appoints Steve Motes as CEO to Drive U.S. Growth in Medical Device Sector

Tulyp Medical Appoints Steve Motes as CEO to Drive U.S. Growth in Medical Device Sector

Tulyp Medical Appoints Steve Motes as CEO to Drive U.S. Growth in Medical Device Sector
Trendline Trendline
Boston Scientific Initiates $2 Billion Accelerated Share Repurchase to Enhance Shareholder Value

Boston Scientific Initiates $2 Billion Accelerated Share Repurchase to Enhance Shareholder Value

Boston Scientific Initiates $2 Billion Accelerated Share Repurchase to Enhance Shareholder Value
Trendline Trendline
AI Transforms Medical Device Industry with New Growth Opportunities

AI Transforms Medical Device Industry with New Growth Opportunities

AI Transforms Medical Device Industry with New Growth Opportunities
Trendline Trendline
Plant-Based Cardiologist Offers Tips for Increasing Fiber Intake

Plant-Based Cardiologist Offers Tips for Increasing Fiber Intake

Plant-Based Cardiologist Offers Tips for Increasing Fiber Intake
Trendline Trendline
Boston Scientific Initiates $2 Billion Accelerated Share Repurchase Agreement with JPMorgan

Boston Scientific Initiates $2 Billion Accelerated Share Repurchase Agreement with JPMorgan

Boston Scientific Initiates $2 Billion Accelerated Share Repurchase Agreement with JPMorgan
Trendline Trendline
Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact

Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact

Revolution Medicines' Pancreatic Cancer Drug Poised for FDA Approval, Analysts Predict Major Impact
Trendline Trendline
Orthofix to Engage in Key June 2026 Investor Conferences, Highlighting Strategic Initiatives

Orthofix to Engage in Key June 2026 Investor Conferences, Highlighting Strategic Initiatives

Orthofix to Engage in Key June 2026 Investor Conferences, Highlighting Strategic Initiatives
Trendline Trendline
Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements

Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements

Entrada Therapeutics Faces Fraud Investigation Over Misleading Investor Statements
Trendline Trendline
Nordic Walking Shows Significant Heart Health Benefits for Coronary Artery Disease Patients

Nordic Walking Shows Significant Heart Health Benefits for Coronary Artery Disease Patients

Nordic Walking Shows Significant Heart Health Benefits for Coronary Artery Disease Patients